4 papers and 0 clinical trials exploring ayahuasca as a treatment for veterans.
Ayahuasca is a botanical decoction combining DMT with MAO-inhibiting harmala alkaloids, producing intense psychedelic effects lasting 3-6 hours. Clinical trials show rapid, large antidepressant effects from a single dose, with a favourable safety profile in controlled settings.
Full Ayahuasca profileVeterans carry an unusually heavy burden of PTSD, depression, traumatic brain injury, moral injury and suicidality, and many do not respond to standard treatment. That unmet need has put them at the centre of psychedelic research, and of an intense real-world demand. The evidence is genuinely promising but still early and mostly uncontrolled, and in 2024 the US FDA declined to approve MDMA-assisted therapy for PTSD.
Full Veterans profileNo clinical trials have been tagged with both Ayahuasca and Veterans yet.
Trials are continuously being added as new studies are registered.